Venlafaxine hydrochloride
Venlafaxine hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Venlafaxine hydrochloride; Generic name: VENLAFAXINE HYDROCHLORIDE; Manufacturer: Dr. Reddy's Laboratories Limited.
| Brand name | Venlafaxine hydrochloride |
|---|---|
| Generic name | VENLAFAXINE HYDROCHLORIDE |
| Manufacturer | Dr. Reddy's Laboratories Limited |
| Used for | INDICATIONS AND USAGE Venlafaxine tablets are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ). A major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include |
| Dosage | DOSAGE AND ADMINISTRATION Initial Treatment The recommended starting dose for venlafaxine tablets are 75 mg/day, administered in two or three divided doses, taken with food. Depending on tolerability and the need for further clinical effect, the dose may be increased to 150 mg/day. If needed, the dose should be further increased up to 225 mg/day. When increasing the dose, increments of up to 75 mg/day should be made at intervals of no less than 4 days. In outpatient settings there was no evidenc |
| Warnings | WARNINGS Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are t |
| Active ingredient(s) | VENLAFAXINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=106d0d7b-925b-74e7-83cb-562144ce1f92 |